StageZero Life Sciences Ltd.

TSX:SZLS Stock Report

Mkt Cap: CA$6.4m

StageZero Life Sciences Management

Management criteria checks 2/4

Key information

James Howard-Tripp

Chief executive officer

US$270.0k

Total compensation

CEO salary percentagen/a
CEO tenure6.8yrs
CEO ownership0.2%
Management average tenureno data
Board average tenure15yrs

Recent management updates

Recent updates

Imagine Holding StageZero Life Sciences (TSE:SZLS) Shares While The Price Zoomed 465% Higher

Jan 25
Imagine Holding StageZero Life Sciences (TSE:SZLS) Shares While The Price Zoomed 465% Higher

CEO

James Howard-Tripp

6.8yrs

Tenure

US$270,000

Compensation

Mr. James R. Howard-Tripp has been the Executive Chairman of StageZero Life Sciences Ltd. (formerly known as GeneNews Limited) (also known as ChondroGene Ltd.) since July 12, 2013 and has been its Chief Ex...


Board Members

NamePositionTenureCompensationOwnership
James Howard-Tripp
Executive Chairman & CEO21.3yrsUS$270.00k0.25%
$ 15.7k
Rory Riggs
Independent Director23.3yrsUS$40.00k1.69%
$ 107.8k
Garth A. MacRae
Independent Director23yrsUS$40.00k0.14%
$ 8.8k
Lawrence Cohen
Member of Colorectal Cancer Clinical Advisory Board14.5yrsno datano data
David Sidransky
Member of Colorectal Cancer Clinical Advisory Boardno datano datano data
Khursheed Jeejeebhoy
Member of Colorectal Cancer Clinical Advisory Board14.5yrsno datano data
Harry Glorikian
Independent Director15yrsUS$40.00k0.10%
$ 6.4k
Richard Wender
Member of Colorectal Cancer Clinical Advisory Boardno datano datano data
Bernard Levin
Chairman of Colorectal Cancer Clinical Advisory Board15.8yrsno datano data
David Lieberman
Member of Colorectal Cancer Clinical Advisory Boardno datano datano data
Barry Stein
Member of Colorectal Cancer Clinical Advisory Board14.5yrsno datano data
Jeffrey Baker
Member of Colorectal Cancer Clinical Advisory Board14.5yrsno datano data

15.0yrs

Average Tenure

69yo

Average Age

Experienced Board: SZLS's board of directors are seasoned and experienced ( 15 years average tenure).